Episode Details

Cybin (NYSE:CYBN) CEO Doug Drysdale will join us to discuss their latest trials, where they reported a 71% remission rate in patients with major depressive disorder (MDD) for their leading compound, CYB003. We’ll ask what’s next regarding their Phase III trial and the performance of the psychedelic stock. Plus, money is moving in the cannabis industry. Cory Azzalino, CEO of Eaze, will join us to highlight the company’s recent news about raising $10 million to acquire select assets of Eaze Technologies. Finally, Adam Goers, SVP of Corporate Affairs at The Cannabist Company Holdings (OTC: CBSTF), will join us to share the latest he’s hearing from Washington and address any concerns about whether Matt Gaetz will still be appointed Attorney General, as announced last week by President-Elect Donald Trump. #mattgaetz #donaldtrump #president #cannabis #cannabisindustry #cybin #psychedelicstocks Want to see more earnings interviews?    • Trump, Gaetz, and Cannabis: A High-St...   Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter! https://newsletter.thedalesreport.com... Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web: Facebook:   / thedalesreport   Twitter:   / thedalesreport   Instagram:   / dalesreport   LinkedIn:

Listen Now